(Photo: Andrey Popov/iStock/Getty Images Plus)
Pro-life advocates suffered a policy setback last week when the Food and Drug Administration lifted existing restrictions on telemedicine abortions for the duration of the COVID-19 pandemic.
This past year, groups supporting legal abortion litigated against Trump administration FDA rules, which required that chemical abortions occur under medical supervision.
Supporters of legal abortion obtained a favorable ruling from a U.S. district court judge in July. However, in January, the U.S. Supreme Court ruled that the Trump administration’s protective rules were constitutional and could remain in place.
However, the Biden administration’s new FDA rules will make it possible for women to obtain chemical abortion drugs by mail and undergo chemical abortions without any in-person medical supervision.
More HERE